Table 1.
ncRNA | Disease Association(s) | Other Notable Function(s) | Citations |
---|---|---|---|
miR-122 | Hepatitis C | [23,24,25,26,27,28] | |
NASH | |||
miR-21 | NASH | Limits regenerative ability | [29,30,31,32,33] |
Hepatocellular carcinoma | |||
let-7a | Hepatocellular carcinoma | Altered following partial hepatectomy | [34,35,36] |
Cholangiocarcinoma | |||
let-7b | Hepatitis C | Downregulated in small volume liver grafts | [36,37,38,39] |
Acetaminophen overdose | Altered following partial hepatectomy | ||
Hepatocellular carcinoma | |||
let-7c | Acetaminophen overdose | Altered following partial hepatectomy | [36,37] |
let-7d | Acetaminophen overdose | Altered following partial hepatectomy | [36,37] |
let-7e | Altered following partial hepatectomy | [36] | |
let-7f | Downregulated in small volume liver grafts | [36] | |
Altered following partial hepatectomy | |||
let-7g | Hepatitis C | Altered following partial hepatectomy | [36,40,41,42,43] |
Hepatocellular carcinoma | |||
let-7i | Altered following partial hepatectomy | [36] | |
miR-451a | Chronic hepatitis B | [44,45] | |
Hepatocellular carcinoma | |||
miR-144 | Chronic hepatitis B | [44,45] | |
Hepatocellular carcinoma | |||
ZSCAN16-AS1 (lncRNA) | Hepatocellular carcinoma | [46] | |
MALAT1 (lncRNA) | Hepatocellular carcinoma NAFLD/NASH Fibrosis |
Liver regeneration | [47,48] |